Comparison of pulmonary function changes between patients receiving neoadjuvant chemotherapy and chemoradiotherapy prior to minimally invasive esophagectomy: a randomized and controlled trial

[1] van Hagen P(2012)Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2074-2084

[2] Hulshof MC(2013)Oesophageal carcinoma Lancet 381 400-412

[3] van Lanschot JJ(2015)Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial Lancet Oncol 16 1090-1098

[4] Steyerberg EW(2011)Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial J Clin Oncol 29 1715-1721

[5] van Berge Henegouwen MI(2015)Multimodality approaches for the curative treatment of esophageal cancer J Natl Compr Canc Netw 13 229-238

[6] Wijnhoven BP(2004)Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications? Ann Thorac Surg 77 260-5

[7] Pennathur A(2014)Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901 J Clin Oncol 32 2416-2422

[8] Gibson MK(2009)Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications Ann Thorac Surg 88 930-5

[9] Jobe BA(2005)Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer Chest 128 250-255

[10] Luketich JD(2015)Outcomes, quality of life, and survival after esophagectomy for squamous cell carcinoma: a propensity score-matched comparison of operative approaches J Thorac Cardiovasc Surg 149 1006-14

[1] van Hagen P(2012)Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2074-2084

[2] Hulshof MC(2013)Oesophageal carcinoma Lancet 381 400-412

[3] van Lanschot JJ(2015)Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial Lancet Oncol 16 1090-1098

[4] Steyerberg EW(2011)Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial J Clin Oncol 29 1715-1721

[5] van Berge Henegouwen MI(2015)Multimodality approaches for the curative treatment of esophageal cancer J Natl Compr Canc Netw 13 229-238

[6] Wijnhoven BP(2004)Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications? Ann Thorac Surg 77 260-5

[7] Pennathur A(2014)Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901 J Clin Oncol 32 2416-2422

[8] Gibson MK(2009)Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications Ann Thorac Surg 88 930-5

[9] Jobe BA(2005)Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer Chest 128 250-255

[10] Luketich JD(2015)Outcomes, quality of life, and survival after esophagectomy for squamous cell carcinoma: a propensity score-matched comparison of operative approaches J Thorac Cardiovasc Surg 149 1006-14